Clinical Trial Update: Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for Sativex (nabiximols) in relieving persistent pain in patients with advanced cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Pain

Drugs mentioned

• Sativex (nabiximol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Pain, Advanced Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-04-23